Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
Cancer Research and Treatment. 2015;47(4):549-554 
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients
Cancer Treatment Reviews. 2013;39(8):839-850
Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation: Response to Chemotherapy
Chest. 2014;146(4):591A
Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer
Lung Cancer. 1989;5(2-3):108
Immunohistochemical evaluatin of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer
Lung Cancer. 1995;13(2):193
Epidermal growth factor receptor (EGFR) in non small cell lung cancer (NSCLC)
Lung Cancer. 1994;11:2
22 Epidermal growth factor receptor (EGFR) mutation testing in non small cell lung cancer – the New Cross Hospital experience
Lung Cancer. 2013;79:S8
Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
Pulmonary Adenocarcinoma: Approaches to Treatment. 2019;115-131
The Role of Mutation Status of the Epidermal Growth Factor Receptor Gene In Advanced Non–Small Cell Lung Cancer
Medicina. 2012;48(4):25
A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2010;11(1):8-12